59 related articles for article (PubMed ID: 6515407)
1. [C-reactive protein and liposomes].
Zeng YH; Wu QZ
Sheng Li Ke Xue Jin Zhan; 1984 Jul; 15(3):228-31. PubMed ID: 6515407
[No Abstract] [Full Text] [Related]
2. The interaction of liposomes with the complement system.
Szebeni J
Crit Rev Ther Drug Carrier Syst; 1998; 15(1):57-88. PubMed ID: 9523086
[TBL] [Abstract][Full Text] [Related]
3. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
Li YP; Mold C; Du Clos TW
J Immunol; 1994 Mar; 152(6):2995-3005. PubMed ID: 8144898
[TBL] [Abstract][Full Text] [Related]
4. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement.
Volanakis JE; Narkates AJ
J Immunol; 1981 May; 126(5):1820-5. PubMed ID: 7217669
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae.
Mold C; Gewurz H
J Immunol; 1981 Nov; 127(5):2089-92. PubMed ID: 6913608
[TBL] [Abstract][Full Text] [Related]
6. Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding.
Mold C; Rodgers CP; Richards RL; Alving CR; Gewurz H
J Immunol; 1981 Mar; 126(3):856-60. PubMed ID: 7462634
[TBL] [Abstract][Full Text] [Related]
7. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes.
Wolbink GJ; Brouwer MC; Buysmann S; ten Berge IJ; Hack CE
J Immunol; 1996 Jul; 157(1):473-9. PubMed ID: 8683153
[TBL] [Abstract][Full Text] [Related]
8. Change in permeability of liposomal membranes mediated by C-reactive protein and its inhibition by cholesterol.
Ohsawa T
Jpn J Exp Med; 1980 Feb; 50(1):67-71. PubMed ID: 7382134
[TBL] [Abstract][Full Text] [Related]
9. [Liposome interaction with cells. Liposomes with a liquid-crystal membrane].
Margolis LB; Neĭfakh AA
Usp Sovrem Biol; 1982; 93(2):214-29. PubMed ID: 7048783
[No Abstract] [Full Text] [Related]
10. Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation.
Szebeni J; Wassef NM; Spielberg H; Rudolph AS; Alving CR
Biochem Biophys Res Commun; 1994 Nov; 205(1):255-63. PubMed ID: 7999033
[TBL] [Abstract][Full Text] [Related]
11. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
[TBL] [Abstract][Full Text] [Related]
12. Effect of IgG and C-reactive protein on complement depletion by monosodium urate crystals.
Russell IJ; Papaioannou C; McDuffie FC; MacIntyre S; Kushner I
J Rheumatol; 1983 Jun; 10(3):425-33. PubMed ID: 6887165
[TBL] [Abstract][Full Text] [Related]
13. [Reactive compounds in acute diseases--C-reactive protein].
Zhao XZ
Sheng Li Ke Xue Jin Zhan; 1980; 11(1):48-54. PubMed ID: 7433954
[No Abstract] [Full Text] [Related]
14. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
[TBL] [Abstract][Full Text] [Related]
15. Pentameric two-dimensional crystallization of rabbit C-reactive protein on lipid monolayers.
Wang HW; Sui S
J Struct Biol; 1999 Oct; 127(3):283-6. PubMed ID: 10544054
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
Bradley AJ; Devine DV; Ansell SM; Janzen J; Brooks DE
Arch Biochem Biophys; 1998 Sep; 357(2):185-94. PubMed ID: 9735159
[TBL] [Abstract][Full Text] [Related]
17. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
Bhakdi S; Torzewski M; Paprotka K; Schmitt S; Barsoom H; Suriyaphol P; Han SR; Lackner KJ; Husmann M
Circulation; 2004 Apr; 109(15):1870-6. PubMed ID: 15037531
[TBL] [Abstract][Full Text] [Related]
18. Activation of human complement by liposomes: serum factor requirement for alternative pathway activation.
Mold C; Gewurz H
J Immunol; 1980 Aug; 125(2):696-700. PubMed ID: 7391575
[No Abstract] [Full Text] [Related]
19. Application of liposomal membranes to the analysis of the triggering mechanism of sperm acrosomal reaction.
Ohsawa T; Masuda M
Jpn J Exp Med; 1981 Feb; 51(1):21-8. PubMed ID: 7311077
[TBL] [Abstract][Full Text] [Related]
20. Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.
Szebeni J
Crit Rev Ther Drug Carrier Syst; 2001; 18(6):567-606. PubMed ID: 11789676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
